oftenof greaterclinical valuethan that of serum folate [3] . Yet, there exists no reference method for the preparation of wholeblood samples for use in determination of RBC folate. Variability in the ability to assay RBC folate with commercial competitive-binding kits and microbiological assays involving Lactobacillus casei has been reported repeatedly [4] [5] [6] [7] . Explanations offered for the different results and the imprecision have primarily focused on assay conditions, e.g., pH, extraction temperature, the condition and type of binders, and the standards used [7] . Shane et al. determined that the microbiological assay was unsuitable for the measurement of folate polyglutamates but gave accurate results for the assessment of folates provided they are converted to the monoglutamate forms before assay; commercial competitive-binding assays gave variable responses to polyglutamates compared with monoglutamates [8] . This emphasizes the importance of sample preparation and of verification of the extent of deconjugation of the 5-methyltetrahydrofolate polyglutamates in the whole-blood sample applied to the folate assay.
Neither the microbiological assay nor competitive binding assay methods offer the possibility to determine simultaneously the composition of the different folate vitamers in the tested sample. However, chromatographic methods such as ion exchange or reversed-phase HPLC can ensure the separation and determination of various folates [9] . Different HPLC methods for the separation of folate polyglutamates have been developed, but most of them involve gradient separation and have a run time of -1 h, and none has been applied for the separation of RBG polyglutamates [10] [11] [12] [13] [14] [15] [16] [17] . The objective of this study was to develop a rapid, sensitive, and specific chromatographic assay that allows simultaneous determination of RBC folates and verification of the deconjugation of RBC folate polyglutamates depending on varying conditions of sample preparation. This communication describes a modification and application of the reversed-phase fluorometric HPLC procedure of Gregory et al. [18, 19] . A 3-cm-long HPLC column packed with 3-jtm octadecylsilica was used in conjunction with isocratic mobile phase at pH 2.3, which allowed rapid and efficient separation of [20] . A secondary objective of this study was to determine optimal conditions for preparation and handling of blood before folate assay.
Materials and Methods

CHEMICALS
All chemicals used were reagent grade or the highest available were added. Nitrogen gas was bubbled through the sample for 10 s, followed by immediate capping.
Thermal extraction was performed by incubation in a boiling water bath for 10 mm. After cooling on ice, centrifugation followed at 10 000g for 10 mm at 5 #{176}C. The supernatant was poured off, bubbled with nitrogen gas for 10 s, and loaded on a FBP-Affigel 10 column (0.5-mL bed volume, -2 tg binding capacity) that had been previously equilibrated with 0.1 mollL potassium phosphate buffer, pH 7.0. All sample application, wash, and elution steps were conducted at ambient temperature at a flow rate of 0.3 mL/min as controlled by a peristaltic pump.
The columns were washed with two 1-mL portions of 0.025 molfL potassium phosphate, pH 7.0, containing 1.0 molJL NaCI, followed by two l-mL washes with 0.025 mol/L potassium phosphate, 
MICROBIOLOGICAL ASSAY
The total folate content of whole-blood samples subjected to different sample preparations was also determined by microbiological assay with L. casei [27] with folic acid casei medium (Difco Labs., Detroit, MI), run at pH 6.8. At this pH, 5-methyltetrahydrofolate may be underestimated with a folic acid calibrant [28] . We found that the pH of the incubation mixture is a critical factor for effective deconjugation. Table 2 shows the percentage distribution of 5-methyltetrahydrofolate polyglutamates relative to the total folate content for the various sample preparations.
Results
Total folate contents were calculated on the basis of equal molar response for each 5-methyltetrahydrofolate polyglutamate.
Blood diluted with 10 gil sodium ascorbate (final pH -7) showed even after 90 mm of incubation at 37 #{176}C the whole array of 5-methyltetrahydrofolate polyglutamates, with only a small shift to polyglutamates of shorter chain length, compared with a sample without incubation ( Table 2 and Fig. 3) . Results obtained by supplementing whole blood (diluted with 10 g/L sodium ascorbate, no incubation) with 5-methyltetrahydrofolate monoglutamate and with 5-methyltetrahydrofolate heptaglutamate for reference are shown in Fig. 4 and contribute to the identification of the various 5-methyltetrahydrofolate polyglutamates. Dilution of whole blood with 10 gil ascorbic acid (final pH -4) provided a fast deconjugation. Incubations of diluted whole blood for 0, 15, 30, 60, and 90 mm at ambient temperature and at 37 #{176}C were studied ( Table 2) . Although the chromatogram of a sample without incubation after ascorbic acid addition showed a mixture of all the different chain lengths (Fig. 5) , after 15 mm of incubation at ambient temperature, only 5-methyltetrahydrofolates with chain lengths of up to four glutamate residues could be found. After 30 mm at 37 #{176}C, only 5-methyltetrahydrofolate mono-, di-, and triglutamates were detected (Fig. 5) ; after 60 mm at 37 #{176}C, only mono-and diglutamate was present; and after 90 mm at 37 #{176}C, 5-methyltetrahydrofolate monoglutamate was the only derivative found (Fig. 5) .
The activity of endogenous plasma pteroylpolyglutamate hydrolase was tested at different pH values by incubation of whole blood diluted with 10 g/L sodium ascorbate, pH adjusted to 4.5, 5.0, or 6.0 (with 0.1 mol/L HCI), for 90 mm at 37 #{176}C.
Incubations at pH 4.5 and 5.0 resulted in mainly 5-methyltetrahydrofolate monoglutamate (75%), with 25% residual diglutamate, whereas samples incubated at pH 6.0 showed an incomplete deconjugation (50% mono-, 32% di-, 18% penta-, and trace amounts of tn-, tetra-, and hexaglutamate).
The stability of synthetic 5-methyltetrahydrofolate diluted with 10 gil sodium ascorbate was tested at different pH values (4.5, 5.0, and 6.0) during incubation for 90 mm at 37 #{176}C and diglutamates are hydrolyzed to monoglutamates. Because there is no effective deconjugation of 5-methyltetrahydrofolate polyglutamates at neutral pH, the blood sample diluted with 10 g/L sodium ascorbate and no incubation represents most likely the endogenous RBC folate polyglutamate distribution (Fig. 3) . Under these conditions -95% of the 5-methyltetrahydrofolate content occurs as tetra-(8.8%), penta-(47.2%), hexa-(30.1%), and heptaglutamate (9.4%), while the rest occurs as monoglutamate (4.6%) and trace amounts of di-, tn-, and octaglutamate.
This corresponds closely to reports of Shin et al. [29] , who found that -95% of total folates in RBCs are 5-methyl derivatives of reduced pteroylpolyglutamates, mainly as pentaglutamate (60%) and hexaglutamate (35%). Studies of Erbe [24] and Steinberg [25] showed that in RBCs, folates occur in the polyglutamate form, mainly as tetra-, penta-, and hexaglutamates.
The chromatographic separations of folate polyglutamates used here were based on observations of Bush et al. [20] , who reported that in reversed-phase chromatography the selectivity of separation for polyionogenic compounds can be drastically modulated by changing the pH of the eluent. The elution of folate polyglutamates in reversed-phase chromatography, when the pH of the eluent is sufficiently high for the carboxylic acid groups to be predominantly ionized, should be in the order of decreasing number of glutamyl residues in the molecule (HPLC method II). If, on the other hand, the pH of the eluemt is low 30 minutes at 37C casel.
enough to suppress the ionization of glutamyl carboxyl groups, the elution order will be with increasing chain length (HPLC method I).
The adapted gradient HPLC method II provides a good separation for different folate polyglutamates within 20 mm.
Depending on the mixture to be separated, the gradient can be adjusted appropriately. This method has been applied successfully to the separation of RBC folate polyglutamates (data not shown), but the isocratic HPLC method I reported here seems to be more favorable for this task, since it is faster (no reequilibration time), and the short-chain 5-methyltetrahydrofolate polyglutamates elute first and show a better peak shape. With this HPLC method, RBC 5-methyltetrahydrofolate polyglutamates can be separated within 20 mm. Our findings concerning the importance of the pH and of the sample preparation for the deconjugation of RBC folatepolyglutamates are consistent with the pH optimum of plasma pteroylpolyglutamatehydrolase of 4.5 [30] . In spite of the documented pH profile of this enzyme, there seems to be confusion in the field of folate analysis regarding methods of sample preparation for whole blood. Some laboratories use ascorbic acid solution to dilute the blood [3 , others use sodium ascorbate solution [34, 35] , and still others use sodium ascorbate solution, but adjust the pH to 4.5 [36] or 6.1 [6, 37] . Depending on the method used for the whole-blood folate assay, the use of sodium ascorbate without a pH adjustment might result in an underestimation of the folate content and might lead to false diagnosis of deficiency.
Scott et al. studied the necessity of allowing whole blood to incubate with ascorbic acid before adding the blood-ascorbate mixture to the microbiological assay medium [31] . They found an increase in the microbiological response for up to 15 min of incubation time. If whole blood is analyzed with the microbiological assay, such a short incubation time might be sufficient, since long-chain polyglutamates can be hydrolyzed to triglutamates or shorter, and L. casei responds equally to folic acid mono-, di-, and triglutamates [38] . Reversed-phase highperformance liquid chromatography of the azo dye derivatives of p-aminobenzoylpoly-y-glutamates and its application to the study
